- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 222.48M sh |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $68.2M |
| Short Term Debt | Q1 2025 · Sep 30, 2024 | $83.5M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $117.5M |
| Short Term Investments | Q1 2025 · Sep 30, 2024 | $5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.85B |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $2.98B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $16.69B |
| Stockholders Equity | Q1 2025 · Sep 30, 2024 | $17.04B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.81B |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $4.18B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $21.28B |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $20.9B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.35B |
| Current Assets | Q1 2025 · Sep 30, 2024 | $6.36B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $40.02B |
| Total Assets | Q1 2025 · Sep 30, 2024 | $39.57B |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 222.8M sh |
| Dividends Paid | Q1 2025 · Dec 31, 2023 | $388.9M |
| Capex | Q1 2025 · Dec 31, 2023 | $1.45B |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $626.6M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $2.73 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $2.74 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $238.4M |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $25.7M |
| Net Income | Q1 2025 · Dec 31, 2023 | $609.3M |
| Operating Income | Q1 2025 · Dec 31, 2023 | $666.9M |
| Cost Of Revenue | Q1 2025 · Dec 31, 2023 | $2.07B |
| Revenue | Q1 2025 · Dec 31, 2023 | $3B |